GRANITE |
GRANITE-001; GRT-C901/GRT-R902 |
Phase 3 Clinical |
Bristol-Myers Squibb Company, Gritstone Bio Inc |
Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Transitional Cell; Colonic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
89Zr-Df-crefmirlimab |
IAB-22-M2C |
Phase 3 Clinical |
Imaginab Inc |
Solid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Multiple Sclerosis; Lymphoma; Leukoencephalopathy, Progressive Multifocal; Melanoma; Carcinoma, Non-Small-Cell Lung |
Details
|
RB-0003 |
RB-0003; BNT-111 |
Phase 2 Clinical |
Biontech Se, Tron |
Melanoma |
Details
|
GEN-009 |
GEN-009 |
Phase 2 Clinical |
Genocea Biosciences Inc |
Skin Melanoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung |
Details
|
VE-800 |
VE-800 |
Phase 2 Clinical |
Vedanta Biosciences Inc |
Esophageal Neoplasms; Stomach Neoplasms; Colorectal Neoplasms; Adenocarcinoma; Melanoma; Neoplasm Metastasis |
Details
|
EBViNT Cell (Eutilex) |
|
Phase 2 Clinical |
Eutilex |
Lymphoma, Extranodal NK-T-Cell |
Details
|
ZED88082A |
ZED88082A |
Phase 2 Clinical |
Umcg The University Medical Center Groningen |
Neoplasms; Neoplasm Metastasis |
Details
|
NY-ESO-1-specific autologous CD8+ T-cell therapy (Fred Hutchinson Cancer Research Center) |
|
Phase 1 Clinical |
Fred Hutchinson Cancer Research Center, National Cancer Institute |
Liposarcoma; Sarcoma, Synovial; Sarcoma |
Details
|
Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) |
|
Phase 1 Clinical |
Second Affiliated Hospital School Of Zhejiang University School Of Medicine |
Esophageal Neoplasms; Stomach Neoplasms |
Details
|
SCRI-E2CAR_EGFRtv1 |
SCRI-E2CAR_EGFRtv1 |
Phase 1 Clinical |
Umoja BioPharma Inc |
Osteosarcoma |
Details
|
68-Ga-NODAGA-SNA-006 |
SNA-006; 68-Ga-NODAGA-SNA-006 |
Phase 1 Clinical |
Smartnuclide Biopharma |
Solid tumours |
Details
|